+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

Conventional and Alternative Pain Treatment Markets - Product Thumbnail Image

Conventional and Alternative Pain Treatment Markets

  • Report
  • November 2020
  • 260 Pages
  • Global
From
Non-opioid Pain Treatment: Global Markets to 2024 - Product Thumbnail Image

Non-opioid Pain Treatment: Global Markets to 2024

  • Report
  • December 2019
  • 165 Pages
  • Global
From
Emerging Non-Opioid Pharmaceuticals for Pain Management - Product Thumbnail Image

Emerging Non-Opioid Pharmaceuticals for Pain Management

  • Report
  • May 2020
  • 51 Pages
  • Global
From
From
From
From
From
Neuropathic Pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Neuropathic Pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Peripheral Neuropathic Pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Peripheral Neuropathic Pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Neuropathic Pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Neuropathic Pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Medical Marijuana - Competitive Insight, 2019 - Product Thumbnail Image

Medical Marijuana - Competitive Insight, 2019

  • Report
  • February 2020
  • 101 Pages
  • Global
From
From
From
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more